| Structure | Chemical Name | CAS | MF |
|
(2S,3R)-3-aminobutan-2-ol
|
42551-55-3
|
C4H11NO
|
|
(-)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
|
102579-71-5
|
C6H9NO2
|
|
(1S,2R)-(+)-1-AMINO-PHENYL-2-PROPANOL HCL
|
|
C9H15ClNO
|
|
(2S,3R)-2-amino-3-hydroxy-butanedioic acid
|
1186-90-9
|
C4H7NO5
|
|
((2S,4R)-4-aminopyrrolidin-2-yl)methanol
|
1292324-43-6
|
C5H12N2O
|
|
(2S,4R)-4-AMINO-PYRROLIDINE-2-CARBOXYLIC ACID
|
|
C5H10N2O2
|
|
(1S,2R)-2-{[2-(aminocarbothioyl)hydrazino]carbonyl}cyclohexanecarboxylic acid
|
|
C9H15N3O3S
|
|
|
(1S,2R)-2-({[3-(aminocarbonyl)-5-benzyl-4-methyl-2-thienyl]amino}carbonyl)cyclohexanecarboxylic acid
|
|
C21H24N2O4S
|
|
(2S,4R)-(+)-2-Amino-4-methylpentanedioic acid
|
59685-03-9
|
|
|
2(S),3(R)-2-Amino-3-hydroxypent-4-ynoic acid
|
64918-85-0
|
|
|
(2S,5R)-2-Amino-4-[3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-5-yl]butanoic acid, N2-FMOC protected
|
|
C29H36N2O7
|
|
(1S,2R)-(+)-2-AMINOCYCLOHEPTANECARBOXYLIC ACID HYDROCHLORIDE
|
522644-09-3
|
C8H16ClNO2
|
|
(-)-(1S,4R)-4-AMINOCYCLOPENT-2-ENECARBOXYLIC ACID
|
140860-51-1
|
C6H9NO2
|
|
(2S,4R)-2-AMINO-4-THIOPHEN-2-YLMETHYL-PENTANEDIOIC ACID
|
|
C10H13NO4S
|
|
(1S,2R)-(-)-2-AMINOCYCLOHEX-3-ENECARBOXYLIC ACID HYDROCHLORIDE
|
132487-40-2
|
C7H12ClNO2
|
|
(3S,4R)-4-AMINO-3-HYDROXY-6-METHYLHEPTANOIC
|
49642-11-7
|
C8H17NO3
|
|
(2S,6R)-6-AMINO-2-(2-THIENYL)-1,4-THIAZEPAN-5-ONE
|
|
C9H12N2OS2
|
|
(2S,4R)-4-Aminopyrrolidine-2-carboxylic acid, 4-BOC, N1-FMOC protected
|
|
C25H28N2O6
|
|
|
(-)-(1S,4R)-4-(2'-amino-6'-chloro-9'H-purin-9'-yl)cyclopent-2-enylmethanol
|
118237-87-9
|
|
|
(2S,3R)-3-AMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID
|
76647-67-1
|
C10H13NO3
|
|
(1S,2R)-2-AMINO-CYCLOOCTANECARBOXYLIC ACID HYDROCHLORIDE
|
522644-10-6
|
C9H18ClNO2
|
|
(2S, 4R)-4-AMINO-1-[T-BUTOXYCARBONYL]PYRROLIDINE-2-ETHYLCARBOXYLATE
|
|
C12H22N2O4
|
|
(2S,6R)-6-Amino-2-(2-thienyl)-1,4-thiazepan-5-one
|
110221-26-6
|
C9H12N2OS2
|
|
(2S,4R)-2-AMINO-4-FURAN-2-YLMETHYL-PENTANEDIOIC ACID
|
|
C10H13NO5
|
|
(3S,4R)-4-AMINO-1-BOC-3-METHOXY-PIPERIDINE
|
|
C11H22N2O3
|
|
(2S,3R)-2-AMINO-3-(PHENYLTHIO)BUTANOIC ACID
|
|
C10H13NO2S
|
|
(1S,4R)-4-Aminocyclopent-2-enecarboxylic acid
|
168471-40-7
|
C6H9NO2
|
|
|
(2S,3R)-1-Amino-4-pentene-2,3-diol
|
|
|
|
|
(2S,3R)-2-Amino-3-[4-(4-hydroxy-2,6-diiodophenoxy)phenyl]-3-iodopropanoic acid sodium salt
|
|
|
|
|
(2S,3R)-2-Amino-3-[4-(4-hydroxyphenoxy)-2,6-diiodophenyl]-3-iodopropanoic acid sodium salt
|
|
|
|
|
(2S,3R)-2-Amino-3-[4-(4-hydroxy-2-iodophenoxy)phenyl]-2,3-diiodopropanoic acid sodium salt
|
|
|
|
(2S,3R)-2-Amino-3-[[(2R)-2-amino-2-carboxyethyl]thio]butyric acid
|
42849-30-9
|
|
|
(7S)-7-[[(R)-5-Amino-5-carboxy-1-oxopentyl]amino]-7-methoxy-3-methylcepham-3-ene-4-carboxylic acid
|
34279-69-1
|
|
|
(2S,4R)-2-Amino-4-hydroxypentanoic acid
|
21704-88-1
|
|
|
|
(2S,3R)-2-Amino-3-[4-(4-hydroxyphenoxy)-3-iodophenyl]-2,3-diiodopropanoic acid sodium salt
|
|
|
|
(2S,3R)-2-Amino-3-hydroxy-4-hexynoic acid
|
51939-52-7
|
|
|
|
(2S,3R)-2-Amino-3-[4-(4-hydroxy-2-iodophenoxy)-2-iodophenyl]-3-iodopropanoic acid sodium salt
|
|
|
|
(2S,3R)-2-AMINO-3-HYDROXY-HEXANOIC ACID
|
10148-69-3
|
C6H13NO3
|
|
(1S,4R)-4-AMINO-CYCLOPENT-2-ENECARBOXYLIC ACID HYDROCHLORIDE
|
61865-62-1
|
C6H10ClNO2
|
|
(1S,4R)-4-AMINO-CYCLOPENT-2-ENYL-METHANOL HYDROCHLORIDE
|
77745-28-9
|
C6H12ClNO
|
|
(2S,3R)-2-AMINO-3-HYDROXY-PENTANOIC ACID
|
10148-67-1
|
C5H11NO3
|
|
|
SRBC protein
|
|
|
|
(1S,2R)-2-([(4-ANILINOPHENYL)AMINO]CARBONYL)CYCLOHEXANECARBOXYLIC ACID
|
|
C20H22N2O3
|
|
|
(2S,3R)-2-[(anilinocarbonyl)amino]-3-hydroxybutanoic acid
|
|
|
|
|
(1S,2R)-2-{[2-(anilinocarbonyl)hydrazino]carbonyl}cyclohexanecarboxylic acid
|
|
C15H19N3O4
|
|
|
(1S,2R)-2-{[2-(4-anilino-4-oxobutanoyl)hydrazino]carbonyl}cyclohexanecarboxylic acid
|
|
C18H23N3O5
|
|
|
(1S,2R)-2-{[2-(anilinocarbonyl)anilino]carbonyl}cyclohexanecarboxylic acid
|
|
C21H22N2O4
|
|
|
(1S,2R)-2-[(4-anilinoanilino)carbonyl]cyclohexanecarboxylic acid
|
|
C20H22N2O3
|
|
|
sRANK, Human, Recombinant (Receptor for sRANKL, soluble RANK Ligand, Receptor Activator of NFkB Ligand)
|
|
|
|
|
SRANKLIGAND,RABBITANTI-MOUSE
|
|
|
|
|
SRANKLIGAND,RABBITANTI-MOUSE,BIOTIN
|
|
|
|
|
SRANK(SRECEPTORACTIVATOROFNFKAPPA-B)LIGAND,MOUSE,RECOMBINANT
|
|
|
|
|
SRANK LIGAND, MOUSE
|
|
|
|
|
1-[[(1S,3R)-3,3aα,4,4',5,5',6,7-Octahydro-4,4,5'α,7aβ-tetramethyl-5'β-ethenylspiro[isobenzofuran-1(7aH),2'(3'H)-furan]]-3α-yl]-2-propanone
|
|
|
|
|
1-[[(1S,3R)-3,3a,4,4',5,5',6,7-Octahydro-3aα-hydroxy-4,4,5'α,7aβ-tetramethyl-5'β-ethenylspiro[isobenzofuran-1(7aH),2'(3'H)-furan]]-3α-yl]-2-propanone
|
|
|
|
|
[1S,4R,7-anti,(+)]-Bicyclo[2.2.1]heptane-2α,7-diol
|
|
|
|
|
(1S,4R,7-anti)-7-(Methoxymethyl)bicyclo[2.2.1]hept-5-en-2-one
|
|
|
|
|
(1S,5R,9-anti)-2β-(4-Morpholinyl)bicyclo[3.3.1]nonan-9-ol
|
|
|
|
|
(1S,5R,8-anti)-8-Chloro-5-methoxy-6-methyl-6-azabicyclo[3.2.1]octane
|
|
|
|
|
3-[(1S,4R,7-anti)-3α-Hydroxybicyclo[2.2.1]hept-5-en-7-yl]-2-[2-chloro-1,1-bis(chloromethyl)ethoxycarbonyloxy]acrylic acid methyl ester
|
|
|
|
|
[1S,4R,7-anti,(-)]-Bicyclo[2.2.1]heptane-2α,7-diol diacetate
|
|
|
|
|
[1S,4R,7-anti,(-)]-Bicyclo[2.2.1]heptane-2α,7-diol 7-acetate
|
|
|
|
|
(2S,3R)-2-[(Benzyloxycarbonyl)amino]-5-hexene-1,3-diol
|
|
|
|
|
(2S,3R)-3-(Benzyloxycarbonylamino)-2-hydroxybutyric acid
|
|
|
|
|
(2S,3R)-3-Benzylthio-2-methylbutanoic acid methyl ester
|
|
|
|
|
(2S,3R)-2-[(Benzyloxycarbonyl)amino]-3-hydroxybutanoic acid methyl ester
|
|
|
|
|
(8S,9R)-9-(Benzoyloxy)-6'-methoxycinchonan
|
|
|
|
(3S,4R)-3-BENZYL-1-METHYLPIPERIDIN-4-AMINE
|
952480-26-1
|
C13H20N2
|
|
(4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
|
153652-70-1
|
C19H19NO4
|
|
[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-d9-[(4-nitrophenyl)sulfonyl]amino] propyl]-carbamic Acid tert-Butyl Ester
|
|
C25H35N3O7S
|
|
tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-[isobutyl[(4-nitrophenyl)sulfonyl]amino]propyl]carbamate
|
191226-98-9
|
C25H35N3O7S
|
|
(2S,4R)-3-Benzoyl-4-methyl-2-phenyl-5-oxazolidinone
|
118995-17-8
|
C17H15NO3
|
|
(2S,4R)-3-Benzoyl-4-ethoxylcarbonylmethyl-4-methyl-5-oxazolidinone
|
|
C21H21NO5
|
|
[(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-[(4-aminophenyl)sulfonyl]amino] propyl]-carbamic Acid tert-Butyl Ester
|
183004-94-6
|
C25H37N3O5S
|
|
|
(2S,3R)-2-(benzoylamino)-3-hydroxybutanoic acid
|
|
|
|
|
(2S,3R)-2-[(1,3-benzodioxol-5-ylcarbonyl)amino]-3-hydroxybutanoic acid
|
|
|
|
|
(2S,3R)-2-[(benzylsulfonyl)amino]-3-hydroxybutanoic acid
|
|
|
|
[(1S,2R)-1-BENZYL-2-HYDROXY-3-[ISOBUTYL-(4-NITRO-BENZENESULFONYL)-AMINO]-PROPYL]-CARBAMIC ACID, TERT-BUTYL ESTER
|
|
C25H35N3O7S
|
|
(3S,4R)-4-BENZYL-3-(3-METHYLPENTANOYL)-OXAZOLIDIN-2-ONE
|
228267-64-9
|
|
|
|
(3S,4R)-3-benzyl 4-methyl 1-benzylpyrrolidine-3,4-dicarboxylate
|
|
|
|
|
3S,4R-(1-Benzyl-4-amino-pyrrolidin-3-yl)-acetic acid
|
|
|
|
|
3S,4R-(1-Benzyl-4-tert-butoxycarbonylamino-pyrrolidin-3-yl)-acetic acid
|
|
|
|
(1S,2R)-2-[(BENZYLAMINO)CARBONYL]CYCLOHEXANECARBOXYLIC ACID
|
|
C15H19NO3
|
|
(2S,5R)-5-BENZYL-PIPERIDINE-2-CARBOXYLIC ACID
|
|
C13H17NO2
|
|
2-[(S,R)-2-BENZYLOXY-3-HYDROXY-PENTYL]-1,3-DIOXANE
|
|
C16H24O4
|
|
(2S,5R)-1-Benzyl-2,5-Diisopropyl-Piperazine
|
|
C17H28N2
|
|
(2S,5R)-1-Benzyl-5-Tert-Butyl-2-Methyl-Piperazine
|
|
C16H26N2
|
|
(2S,5R)-1-Benzyl-2-Tert-Butyl-5-Methyl-Piperazine
|
|
C16H26N2
|
|
(2S,5R)-1-Benzyl-2,5-Di-Tert-Butyl-Piperazine
|
|
C19H32N2
|
|
(2S, 3R)-[4-BENZYLOXYPHENYL]-5-OXOPROLINE
|
|
C18H17NO4
|
|
(2S,5R)-6-BENZYLOXYCARBONYLAMINO-2-TERT-BUTOXYCARBONYLAMINO-5-TRIISOPROPYLSILANYLOXY-HEXANOIC ACID
|
|
C28H48N2O7Si
|
|
|
(1S,2R)-2-[(4-{[benzyl(methyl)amino]sulfonyl}anilino)carbonyl]cyclohexanecarboxylic acid
|
|
C22H26N2O5S
|
|
|
(1S,2R)-2-({2-[4-(benzylamino)-4-oxobutanoyl]hydrazino}carbonyl)cyclohexanecarboxylic acid
|
|
C19H25N3O5
|
|
(2S,4R)-BENZYL-BOC-GAMMA-BENZYLPYROGLUTAMATE
|
|
C24H27NO5
|
|
(8S,10R)-10-BENZYLOXY-7-VINYL-HENICOSAN-8-OL
|
|
C30H52O2
|
|
(3S,4R)-1-BENZYL-4-(4-FLUORO-PHENYL)-PIPERIDINE-3-CARBOXYLIC ACID TERT-BUTYL ESTER
|
|
C23H28FNO2
|
|
(2S,5R)-1-Benzyl-2-Isopropyl-5-Methyl-Piperazine
|
|
C15H24N2
|
|
(2S,5R)-1-Benzyl-2-Tert-Butyl-5-Isopropyl-Piperazine
|
|
C18H30N2
|
|
(2S,5R)-1-Benzyl-5-Tert-Butyl-2-Isopropyl-Piperazine
|
|
C18H30N2
|
|
(2S,5R)-1-Benzyl-5-Isopropyl-2-Methyl-Piperazine
|
|
C15H24N2
|